This article Budesonide add-on Therapy Improves Markers of disease activity but fails to improve histology in patients with Primary Biliary Cholangitis appeared first on Project Topics.

13 April 2018, Paris, France: The addition of budesonide is associated with clinically meaningful improvements in biochemical markers of disease activity but no improvement in liver histology in high-risk patients with primary biliary cholangitis (PBC) experiencing a sub-optimal response to ursodeoxycholic acid (UDCA), according to the results of a study presented today. The placebo-controlled study, […]

This article Budesonide add-on therapy improves markers of disease activity but fails to improve histology in patients with primary biliary cholangitis appeared first on Project Topics.